Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
The Diflunisal Trial: study accrual and drug toleranceJohn L Berk, Ole B Suhr, Yoshiki Sekijima, et al.Blood|November 3, 2007
Improved survival in multiple myeloma and the impact of novel therapiesShaji K Kumar, S Vincent Rajkumar, Angela Dispenzieri, et al.Blood|June 24, 2008
Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2Bonnie K Arendt, Marina Ramirez-Alvarado, Laura A Sikkink, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosisAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.Blood|August 25, 2005
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myelomaS Vincent Rajkumar, Suzanne R Hayman, Martha Q Lacy, et al.Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.Blood|December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasmWee J Chng, Greg J Ahmann, Kim Henderson, et al.Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.Pageof 10